» Articles » PMID: 35855047

Acute Acalculous Cholecystitis Following COVID-19 Vaccination: a Case Report

Abstract

Acute acalculous cholecystitis is an acute inflammation of the gallbladder in the absence of stones, usually occurring in elderly and critically ill patients with underlying conditions. A 29-year-old man presented to the hospital complaining of abdominal pain in the right hypochondrium with permanent fever three days after Janssen COVID-19 vaccine inoculation. Abdominal ultrasound revealed a thickened gallbladder wall without evidence of gallstone consistent of an acute acalculous cholecystitis. Blood analyses revealed thrombocytopenia, eosinophilia and liver dysfunction. The Polymerase Chain Reaction (PCR) COVID-19 test was negative. As treatment, the patient benefited of pain management, antibiotic and fluid. In the evolution, there was a regression of clinical signs with persistence of liver dysfunction. The patient was discharged ten days after hospitalization. The Janssen COVID-19 vaccine is likely to induce acute acalculous cholecystitis as adverse event following vaccination.

Citing Articles

Acute abdomen following COVID-19 vaccination: a systematic review.

Cahuapaza-Gutierrez N, Pajuelo-Vasquez R, Quiroz-Narvaez C, Rioja-Torres F, Quispe-Andahua M, Runzer-Colmenares F Clin Exp Vaccine Res. 2024; 13(1):42-53.

PMID: 38362368 PMC: 10864878. DOI: 10.7774/cevr.2024.13.1.42.


New-onset and relapsed liver diseases following COVID-19 vaccination: a systematic review.

Alhumaid S, Mutair A, Rabaan A, ALShakhs F, Choudhary O, Yong S BMC Gastroenterol. 2022; 22(1):433.

PMID: 36229799 PMC: 9559550. DOI: 10.1186/s12876-022-02507-3.


Friend or foe-The Pfizer-BioNTech (BNT162b2) vaccination: A case report of reversible acute acalculous cholecystitis.

Wahlen B, Peralta R, Al-Thani H, El-Menyar A Clin Case Rep. 2022; 10(7):e6078.

PMID: 35846906 PMC: 9280744. DOI: 10.1002/ccr3.6078.

References
1.
Owen C, Jain R . Acute Acalculous Cholecystitis. Curr Treat Options Gastroenterol. 2005; 8(2):99-104. DOI: 10.1007/s11938-005-0001-4. View

2.
Balmadrid B . Recent advances in management of acalculous cholecystitis. F1000Res. 2018; 7. PMC: 6194724. DOI: 10.12688/f1000research.14886.1. View

3.
Ying M, Lu B, Pan J, Lu G, Zhou S, Wang D . COVID-19 with acute cholecystitis: a case report. BMC Infect Dis. 2020; 20(1):437. PMC: 7306929. DOI: 10.1186/s12879-020-05164-7. View

4.
Oliver S, Gargano J, Scobie H, Wallace M, Hadler S, Leung J . The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Janssen COVID-19 Vaccine - United States, February 2021. MMWR Morb Mortal Wkly Rep. 2021; 70(9):329-332. PMC: 7948932. DOI: 10.15585/mmwr.mm7009e4. View

5.
MacNeil J, Su J, Broder K, Guh A, Gargano J, Wallace M . Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients - United States, April 2021. MMWR Morb Mortal Wkly Rep. 2021; 70(17):651-656. PMC: 8084127. DOI: 10.15585/mmwr.mm7017e4. View